Vital Chemtech Limited: Shareholders approve appointment of Secretarial Auditor
Vital Chemtech Limited announced the successful passage of an ordinary resolution to appoint M/s. SCS and Co. LLP as Secretarial Auditor for five years (FY2025-26 to FY2029-30). The decision was made via postal ballot with 100% votes in favour. The results were declared on April 27, 2026.
The appointment of a secretarial auditor is a routine compliance matter and is unlikely to have a significant direct impact on the company's financial performance or stock price.
The announcement details the successful approval of a key appointment by shareholders, indicating smooth corporate governance and positive shareholder engagement.
Vital Chemtech Limited has announced the voting results of its postal ballot, which concluded on April 24, 2026. The primary agenda item was to approve the appointment of M/s. SCS and Co. LLP as the Secretarial Auditor of the Company for a term of five consecutive years, from the Financial Year 2025-26 to the Financial Year 2029-30.
The voting was conducted through remote e-voting, and the results, along with the Scrutinizer's Report, were declared on April 27, 2026. The Ordinary Resolution to appoint M/s. SCS and Co. LLP was passed with the requisite majority.
Out of the total votes polled, 100% of the votes were in favour of the resolution. Promoters and Promoter Group cast 17,587,500 votes in favour, while Public - Non Institutions cast 407,401 votes in favour. There were no votes against the resolution from any category.
The Scrutinizer's Report confirmed that the postal ballot process was conducted fairly and transparently, adhering to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the Companies Act, 2013. The notice for the postal ballot was sent via e-mail on March 25, 2026, and the remote e-voting period commenced on March 26, 2026, and concluded on April 24, 2026.
What to do with a filing like this
Vital Chemtech Limited filed this with the NSE as a statutory disclosure, categorised under shareholder meetings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vital Chemtech Limited. Read the original for the full detail.